Skip to main content
Clinical Trials/CTRI/2015/06/005923
CTRI/2015/06/005923
Completed
Phase 3

A Comparative Study To Determine The Analgesic Efficacy Of Intravenous Magnesium Sulphate Versus Intrathecal Magnesium Sulphate As An Adjuvant To Bupivacaine In Patients Scheduled For Extracapsular Hip Fracture Surgeries Under Spinal Anaesthesia

Department of pharmacology0 sites90 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: null- Extracapsular hip fracture patients
Sponsor
Department of pharmacology
Enrollment
90
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • ASA physical classIandII.
  • BMI 18\.5\-39\.9
  • Patients undergoing extracapsular hip surgeries under subarachnoid block

Exclusion Criteria

  • BMI \> 40\.
  • Absolute contraindications for spinal anaesthesia.
  • Uncontrolled and labile hypertension.
  • Allergic to any of the study drugs.
  • Patients refusal for spinal anaesthesia.

Outcomes

Primary Outcomes

Not specified

Similar Trials